z-logo
open-access-imgOpen Access
Evaluation of high-dose atorvastatin pretreatment influence in patients preconditioning of post coronary artery bypass graft surgery: A prospective triple blind randomized clinical trial
Author(s) -
Misagh Bastani,
Mohammad Bagher Khosravi,
Masih Shafa,
Simin Azemati,
Behzad Maghsoodi,
Elham Asadpour
Publication year - 2021
Publication title -
annals of cardiac anaesthesia/annals of cardiac anaesthesia
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.42
H-Index - 27
eISSN - 0974-5181
pISSN - 0971-9784
DOI - 10.4103/aca.aca_34_19
Subject(s) - medicine , atorvastatin , randomized controlled trial , coronary artery bypass surgery , clinical trial , artery , cardiology , prospective cohort study , surgery , anesthesia
Atorvastatin is considered as lipid reductive drugs with anti-inflammatory and pleotherapic effects in coronary artery bypass graph (CABG).

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here